Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Acta Trop. 2010 Jan;113(1):42-7. doi: 10.1016/j.actatropica.2009.09.003. Epub 2009 Sep 19.
By screening an Echinococcus granulosus cDNA library with IgG4 from patients with active cystic echinococcosis (CE), we identified a cDNA encoding a protein of 19.0 kDa (Eg19). Eg19, in 12% SDS-PAGE in reducing and non-reducing conditions, showed several bands between 19 and 100 kDa. Immunoblotting (IB) analysis detected total IgG, IgG1 and IgG4 specific to the 38/40 kDa band of Eg19 in the 10% of patients' sera. The percentage of total IgG, IgG1 and IgG4-positive sera were significantly higher in sera from patients with active disease and cyst in multiple sites than from patients with inactive disease and cyst in the liver (P<10(-4)). ELISA analysis disclosed that during the follow-up anti-Eg19 antibody concentration decreased over the course of treatment in sera from patients with cured disease. Even if Eg19 appear to have no benefit in the diagnosis of the disease, our data, confirming the presence of antigens inducing both IgG1 and IgG4 during active development of CE, suggest that Eg19 might be a marker of disease status.
通过用 IgG4 从患有活动性囊性包虫病(CE)的患者筛选细粒棘球蚴 cDNA 文库,我们鉴定出一种编码 19.0 kDa 蛋白的 cDNA(Eg19)。在 12% SDS-PAGE 还原和非还原条件下,Eg19 显示出 19 至 100 kDa 之间的多个条带。免疫印迹(IB)分析检测到来自 10%患者血清中 38/40 kDa 带的总 IgG、IgG1 和 IgG4 特异性。与患有非活动性疾病和肝脏囊肿的患者相比,患有活动性疾病和多个部位囊肿的患者的总 IgG、IgG1 和 IgG4 阳性血清的百分比显着更高(P<10(-4))。ELISA 分析显示,在治疗过程中,来自治愈疾病患者的血清中抗-Eg19 抗体浓度随时间降低。即使 Eg19 在疾病诊断中似乎没有益处,但我们的数据证实了在 CE 活动性发展过程中存在诱导 IgG1 和 IgG4 的抗原,表明 Eg19 可能是疾病状态的标志物。